Salipro Biotech announces multi-target research collaboration with additional Top10 pharma company

Swedish biotech company Salipro Biotech AB today announced that it has entered into a multi-target research collaboration with an additional Top10 pharma company to advance programs using the Salipro® platform on challenging drug targets selected by the pharmaceutical partner. In the course of the collaboration, Salipro Biotech will tailor its proprietary platform technology to several challenging membrane protein drug targets to enable structural biology using cryo-electron microscopy (cryoEM) as well as antibody development.

This multi-target deal takes advantage of Salipro Biotech’s unique expertise and proprietary technology to stabilize challenging drug targets such as GPCRs, ion channels and transporters and make them accessible for the development of next generation therapeutics.